<DOC>
	<DOCNO>NCT02098408</DOCNO>
	<brief_summary>Cognitive deficit know core feature schizophrenia seem become manifest prodromal Ultra-High Risk ( UHR ) state psychosis . The cognitive deficit know pose critical barrier functional recovery . Hence vital importance find intervention strategy alleviate cognitive deficit consequently improve daily function , quality life , well prognosis UHR-patients . The investigator examine whether : - Cognitive remediation therapy superior standard treatment improve cognitive function UHR- patient ( null hypothesis : No difference two group ) . - Cognitive remediation therapy superior standard treatment improve psychosocial function clinical symptom UHR-patients ( null hypothesis : No difference two group ) .</brief_summary>
	<brief_title>Effects Neurocognitive Social Cognitive Remediation Patients Ultra-High Risk Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>Age 1840 yr . Fulfill criterion UltraHigh Risk psychosis ( define one follow ) : Vulnerability ( Trait State Risk Factor ) Group : Individuals combination trait risk factor ( schizotypal personality disorder family history psychotic disorder first degree relative ) significant deterioration functioning , sustain low functioning past year . Attenuated Psychotic Symptoms ( APS ) Group : Individuals subthreshold ( intensity frequency ) positive psychotic symptom . The symptom must present past year . Brief Limited Intermittent Psychotic Symptoms Group ( BLIPS ) : Individuals recent history frank psychotic symptom resolve spontaneously ( without antipsychotic medication ) within one week . The symptom must present past year . Provided inform consent . Past history treat untreated psychotic episode one week 's duration longer Psychiatric symptom explain physical illness psychotropic effect acute intoxication ( e.g. , cannabis use ) . Diagnosis serious developmental disorder , e.g , . Asperger 's syndrome Currently receive treatment metylphenidate . Rejects provide informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Ultra-high risk psychosis</keyword>
	<keyword>Schizophrenia prodrome</keyword>
	<keyword>Cognitive remediation</keyword>
</DOC>